Advertisement
Advertisement

LTRN

LTRN logo

Lantern Pharma Inc. Common Stock

3.04
USD
Sponsored
-0.07
-2.41%
Jan 30, 11:44 UTC -5
Open

LTRN Earnings Reports

Positive Surprise Ratio

LTRN beat 16 of 21 last estimates.

76%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.46
Implied change from Q3 25 (Revenue/ EPS)
--
/
+17.95%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-14.81%

Lantern Pharma Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, LTRN reported earnings of -0.39 USD per share (EPS) for Q3 25, beating the estimate of -0.47 USD, resulting in a 18.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.46 USD, with revenue projected to reach -- USD, implying an increase of 17.95% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Lantern Pharma Inc. Common Stock reported EPS of -$0.39, beating estimates by 18.65%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.57%, changed from $3.48 before the earnings release to $3.46 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 3 analysts, Lantern Pharma Inc. Common Stock is expected to report EPS of -$0.46 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement